Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

GCC 1366: Anti-Proliferative Response to NeoAdjuvant AIs in Overweight and Obese Patients

This study is currently recruiting participants. (see Contacts and Locations)
Verified May 2016 by University of Maryland
Information provided by (Responsible Party):
Susan Kesmodel, University of Maryland Identifier:
First received: March 20, 2014
Last updated: May 10, 2016
Last verified: May 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: March 2019
  Estimated Primary Completion Date: March 2018 (Final data collection date for primary outcome measure)